tiprankstipranks
COSCIENS Biopharma (DE:ET80)
FRANKFURT:ET80
Germany Market
ET80
COSCIENS Biopharma
RESEARCH TOOLSreports

COSCIENS Biopharma (ET80) Income Statement

0 Followers

COSCIENS Biopharma Income Statement

Last quarter (Q2 2026), COSCIENS Biopharma's total revenue was $3.06M, an increase of 9.99% from the same quarter last year. In Q2, COSCIENS Biopharma's net income was $-196.79K. See COSCIENS Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 7.63M$ 9.59M$ 4.50M$ 14.57M$ 5.26M
Gross Profit
$ 2.69M$ 4.73M$ 4.28M$ 8.56M$ 5.17M
Operating Expenses
$ 13.32M$ 18.75M$ 22.28M$ 28.21M$ 13.84M
Depreciation and Amortization
$ 1.21M$ 1.61M$ 16.00K$ 16.00K$ 145.00K
EBITDA
$ -9.41M$ -13.49M$ -17.99M$ -15.36M$ 2.85M
Operating Income
$ -10.62M$ -14.02M$ -18.01M$ -15.38M$ -8.67M
Other Income/Expenses
$ 94.63K$ -1.20M$ 1.46M$ -7.35M$ 194.00K
Pretax Income
$ -10.53M$ -15.22M$ -16.55M$ -22.73M$ -8.48M
Net Income
$ -10.54M$ -15.31M$ -3.55M$ 3.24M$ 2.64M
Per Share Metrics
Basic EPS
$ -29.97$ -17.79$ -5.67$ 5.61$ 3.99
Diluted EPS
$ -29.97$ -17.79$ -5.67$ 5.58$ 3.99
Weighted Average Shares Outstanding
 351.70K 860.44K 539.54K 539.54K 510.78K
Weighted Average Shares Outstanding (Diluted)
 351.70K 860.44K 539.54K 539.54K 510.78K
Currency in USD

COSCIENS Biopharma Earnings and Revenue History